Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Obesity

3,4-methylenedioxyamphetamine has been researched along with Obesity in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Haines, J1
Charlton, BM1
VanderWeele, TJ1
Strain, GW1
Strain, JJ1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Obesity

ArticleYear
Positive parenting improves multiple aspects of health and well-being in young adulthood.
    Nature human behaviour, 2019, Volume: 3, Issue:7

    Topics: Adolescent; Child; Depression; Family Relations; Feeding and Eating Disorders; Female; Health Status

2019
Psychological impediments to weight loss.
    International journal of obesity, 1979, Volume: 3, Issue:2

    Topics: Anxiety, Separation; Body Image; Family; Fear; Female; Guilt; Humans; Love; Male; Obesity; Pain; Sex

1979